Quidel Corp (QDEL) Tops Q3 EPS by $1.84

Go back to Quidel Corp (QDEL) Tops Q3 EPS by $1.84

Quidel Reports Third Quarter 2021 Financial Results

November 4, 2021 4:10 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2021.

Third Quarter 2021 Highlights

Total revenues increased 7% to $509.7 million, from $476.1 million in the third quarter of 2020. Total sales of COVID-19 products increased 7% to $402.6 million, from $375.7 million in the third quarter of 2020. Total sales of Influenza products were $13.8 million, compared to $9.0 million in the third quarter of 2020. Reported GAAP... More